title: Functional genomics to uncover drug mechanism of action.
abstract: The upswing in US Food and Drug Administration and European Medicines Agency drug approvals in 2014 may have marked an end to the dry spell that has troubled the pharmaceutical industry over the past decade. Regardless, the attrition rate of drugs in late clinical phases remains high, and a lack of target validation has been highlighted as an explanation. This has led to a resurgence in appreciation of phenotypic drug screens, as these may be more likely to yield compounds with relevant modes of action. However, cell-based screening approaches do not directly reveal cellular targets, and hence target deconvolution and a detailed understanding of drug action are needed for efficient lead optimization and biomarker development. Here, recently developed functional genomics technologies that address this need are reviewed. The approaches pioneered in model organisms, particularly in yeast, and more recently adapted to mammalian systems are discussed. Finally, areas of particular interest and directions for future tool development are highlighted.
authors.affiliation: Ludwig Institute for Cancer Research Ltd., Oxford, UK.|Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.|Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna, Austria..
authors.forename: Sebastian M B
authors.initials: SM
authors.lastname: Nijman
mesh_terms: D000818:Animals; D023281:Genomics; D006801:Humans; D004364:Pharmaceutical Preparations
chemical_list: D004364:Pharmaceutical Preparations